The Evolution of BioSense: Lessons Learned and Future Directions

Description: 

The BioSense program was launched in 2003 with the aim of establishing a nationwide integrated public health surveillance system for early detection and assessment of potential bioterrorism-related illness. The program has matured over the years from an initial Centers for Disease Control and Prevention–centric program to one focused on building syndromic surveillance capacity at the state and local level. The uses of syndromic surveillance have also evolved from an early focus on alerts for bioterrorism-related illness to situational awareness and response, to various hazardous events and disease outbreaks. Future development of BioSense (now the National Syndromic Surveillance Program) includes, in the short term, a focus on data quality with an emphasis on stability, consistency, and reliability and, in the long term, increased capacity and innovation, new data sources and system functionality, and exploration of emerging technologies and analytics.

Primary Topic Areas: 
Original Publication Year: 
2017
Event/Publication Date: 
July, 2017

August 28, 2017

Contact Us

INTERNATIONAL SOCIETY FOR
DISEASE SURVEILLANCE

288 Grove Street, Box 203
Braintree, MA 02184
(617) 779 0880
Email:syndromic@syndromic.org

This Knowledge Repository is made possible through the activities of the Centers for Disease Control and Prevention Cooperative Agreement/Grant #1 NU500E000098-01, National Surveillance Program Community of Practice (NSSP-CoP): Strengthening Health Surveillance Capabilities Nationwide, which is in the interest of public health.

Site created by Fusani Applications